Corticotropin‐releasing hormone (CRH) in psychiatry: from stress to psychopathology

References

• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394–7.
   PubMed Web of Science ®Google Scholar
• Swanson LW, Simmons DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 1989;285:413–35.
   PubMed Web of Science ®Google Scholar
• Herman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, et al. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 1989;9:3072–82.
   PubMed Web of Science ®Google Scholar
• Makino S, Shibasaki T, Yamauchi N, Nishioka T, Mimoto T, Wakabayashi I, et al. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res 1999;850:136–43.
   PubMedGoogle Scholar
• Davis M. The role of the amygdala in conditioned fear. In: Aggleton JP, ed. The amygdala. New York: Wiley-Liss; 1992:255–306.
   Google Scholar
• Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organiza-tion of ovine corticotropin-releasing factor immuno-reactive cells and fibers in the rat brain: an immunohisto-chemical study. Neuroendocrinology 1983;36:165–86.
   PubMed Web of Science ®Google Scholar
• Austin MC, Janosky JE, Murphy HA. Increased cortico-tropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 2003;8:324–32.
   Google Scholar
• Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992;13:164–91.
   PubMed Web of Science ®Google Scholar
• Heinrichs SC, MM H, Tamraz S, Carmouche M, Boehme SA, Vale WW. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpres-sion are centrally mediated. Psychoneuroendocrinology 1997;22:215–24.
   Google Scholar
• Heinrichs SC, Richard D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 1999;33:350–9.
   PubMed Web of Science ®Google Scholar
• Raza J, Massoud AF, Hindmarsh PC, Robinson IC, Brook CG. Direct effects of corticotropin-releasing hormone on stimulated growth hormone secretion. Clin Endocrinol 1998; 48:217–22.
   Google Scholar
• Nikolarakis KE, Almeida OF, Herz A. Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hor-mone (GnRH) release from superfused rat hypothalami in vitro. Brain Res 1986;377:388–90.
   Google Scholar
• Makino S, Hashimoto K, Gold PW. Multiple feedback mechanisms activating corticotropin-releasing hormone sys-tem in the brain during stress. Pharmacol Biochem Behav 2002;73:147–58.
   Google Scholar
• Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 1995;15:2680–95.
   Google Scholar
• Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002;7:254–75.
   PubMed Web of Science ®Google Scholar
• Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomo-graphy. Biol Psychiatry 1997;41:1140–2.
   Google Scholar
• Pacak K, Tjurmina 0, Palkovits M, Goldstein DS, Koch CA, Hoff T, et al. Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study. Neuroendocrinology 2002;76: 148–57.
   Google Scholar
• Vazquez DM. Stress and the developing limbic-hypothala-mic-pituitary-adrenal axis. Psychoneuroendocrinology 1998; 23:663–700.
   PubMed Web of Science ®Google Scholar
• Plotsky PM, Meaney MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res 1993;18:195–200.
   PubMedGoogle Scholar
• Ladd CO, Owens MJ, Nemeroff CB. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 1996;137:1212–8.
   Google Scholar
• Huot RL, Plotsky PM, Lenox RH, McNamara RK. Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res 2002;950:52–63.
   PubMed Web of Science ®Google Scholar
• Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA 1996;93:1619–23.
   PubMed Web of Science ®Google Scholar
• Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000;284:592–7.
   PubMed Web of Science ®Google Scholar
• Vythilingam M, Heim C, Newport J, Miller AH, Anderson E, Bronen R, et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002;159:2072–80.
   PubMed Web of Science ®Google Scholar
• Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979–86.
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Perel JM, Comes C, Jarrett DB, Mallinger AG, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093–9.
   PubMed Web of Science ®Google Scholar
• Vaillant GE. Natural history of male psychological health, XIV: Relationship of mood disorder vulnerability to physical health. Am J Psychiatry 1998;155:184–91.
   PubMed Web of Science ®Google Scholar
• Pratt LA, Ford DE, Crum RM, Armenian FIK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123–9.
   Google Scholar
• Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, et al. Bone mineral density in women with depression. N Engl J Med 1996;335:1176–81.
   PubMed Web of Science ®Google Scholar
• Carpenter WT, Jr, Bunney WE, Jr. Adrenal cortical activity in depressive illness. Am J Psychiatry 1971;128:31–40.
   PubMed Web of Science ®Google Scholar
• Sachar EJ, Hellman L, Fukushima DK, Gallagher TF. Cortisol production in depressive illness. A clinical and bio-chemical clarification. Arch Gen Psychiatry 1970;23:289–98.
   PubMed Web of Science ®Google Scholar
• McClure DJ. The diurnal variation of plasma cortisol levels in depression. J Psychosom Res 1966;10:189–95.
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA. Urinary free cortisol excretion in depression. Psychol Med 1976;6:43–50.
   Google Scholar
• Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002;52:381–5.
   Google Scholar
• Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477–501.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Krishnan KR, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depres-sion: a computed tomographic study. Arch Gen Psychiatry 1992;49:384–7.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog Brain Res 1990;86:13–23.
   PubMed Web of Science ®Google Scholar
• Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and and Cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756–65.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157:115–8.
   PubMed Web of Science ®Google Scholar
• Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000;47:1087–90.
   Google Scholar
• Posener JA, Wang L, Price JL, Gado MH, Province MA, Miller MI, et al. High-dimensional mapping of the hippo-campus in depression. Am J Psychiatry 2000;160:83–9.
   Google Scholar
• McQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003;100:1387–92.
   Google Scholar
• Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF cortico-tropin-releasing factor-like immunoreactivity in depressed patients. Science 1984;226:1342–4.
   PubMed Web of Science ®Google Scholar
• Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB. CSF corticotropin-releasing factor-like immunoreac-tivity in depression and schizophrenia. Am J Psychiatry 1987; 144: 873–7.
   PubMed Web of Science ®Google Scholar
• Risch SC, Lewine RJ, Kahn NH, Jewart RD, Rishy ED, Caudle JM, et al. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-hrain ratio studies in affective illness and schizophrenia. Neuropsychopharmacology 1992; 6:95–100
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988;45:577–9.
   Google Scholar
• Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, et al. Expression of corticotropin releasing hormone recep-tors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001;6:540–6.
   PubMed Web of Science ®Google Scholar
• Raadsheer FC, van Heerikhuize JJ, Lucassen PJ Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372–6.
   PubMed Web of Science ®Google Scholar
• Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001;158:575–81.
   Google Scholar
• Nemeroff CB. New vistas in neuropeptide research in neuro-psychiatry: focus on corticotropin-releasing factor. Neuro-psychiatry: focus on corticotropin-releasing factor. Neuro-psychopharmacology 1992;6:69–75.
   Google Scholar
• Heim C, Nemeroff CB. The impact of early adverse experi-ences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol Psychiatry 1999;46:1509–22.
   PubMed Web of Science ®Google Scholar
• Newport DJ, Heim C, Owens MJ, Ritchie JC, Ramsey CH, Bonsall R, et al. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pitui-tary response in the CRF stimulation test: a multiple regression analysis. Neuropsychopharmacology 2003; 28: 569–76.
   Google Scholar
• Holsboer F, Liebl R, Hofschuster E. Repeated dexametha-sone suppression test during depressive illness. J Affect Disord 1988;4:93–101.
   Google Scholar
• APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253–62.
   Google Scholar
• Ribeiro SC, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993;150:1618–29.
   PubMed Web of Science ®Google Scholar
• Holsboer-Trachsler E, Stohler R, Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res 1991;38:163–71.
   Google Scholar
• Zobel AW, Yassouridis A, Friesboer RM, Holsboer F. Prediction of medium-term outcome by cortisol response to the combined Dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 1999;156:949–51.
   PubMed Web of Science ®Google Scholar
• Reul JM, de Kloet ER. Two receptor systems for cortico-sterone in rat brain: microdistribution and differential occupation. Endocrinology 1985;117:2505–11.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391–404.
   PubMed Web of Science ®Google Scholar
• Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003;60:24–8.
   PubMed Web of Science ®Google Scholar
• Zobel AW, Nickel T, Künzel HE, Ackl N, Sonntag A, Ising M, et al. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 2000;34: 171–81.
   Google Scholar
• Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuro-endocrinology 1995;62:340–7.
   PubMed Web of Science ®Google Scholar
• Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 1998;18:253–62.
   PubMed Web of Science ®Google Scholar
• Villafuerte SM, Del-Favero J, Adolfsson R, Souery D, Massat I, Mendlewicz J, et al. Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am J Med Genet 2002;114:222–6.
   Google Scholar
• Claes S, Villafuerte S, Forsgren T, Sluijs S, Del-Favero J, Adolfsson R, et al. The CRH binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry; in press.
   Google Scholar
• Catalan R, Gallarta JM, Castellanosa JM, Galarda R. Plasma corticotropin-releasing factor in depressive disorders. Biol Psychiatry 1998;44:15–20.
   PubMedGoogle Scholar
• Oshima A, Yamashita S, Owashi T, Murata T, Tadokoro C, Miyaoka H, et al. The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. J Psychiatr Res 2000; 34:325–8.
   Google Scholar
• Casper RC, Kocsis J, Dysken M, Stokes P, Croughan J, Maas J. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase. J Affect Disord 1988; 15:131–40.
   PubMed Web of Science ®Google Scholar
• Geracioti TD, Jr, Loosen PT, Orth DN. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry 1997;42:165–74.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997;154:624–9.
   PubMed Web of Science ®Google Scholar
• Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999;156:585–8.
   PubMed Web of Science ®Google Scholar
• Smith MA, Davidson J, Ritchie JC, Kudler H, Lipper S, Chappell P, et al. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychia-try 1989;26:349–55.
   PubMed Web of Science ®Google Scholar
• Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry 2001;62 (Suppl 17):41–6.
   PubMedGoogle Scholar
• Rasmusson A, Lipschitz DS, Wang S, Hu S, Vojvoda D, Bremner D, et al. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry 2001;50:965–77.
   PubMed Web of Science ®Google Scholar
• Stein MB, Yehuda R, Koverola C, Hanna C. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psy-chiatry 1997;42:680–6.
   PubMed Web of Science ®Google Scholar
• Yehuda R, Boisoneau D, Lowy MT, Giller EL, Jr. Dose-response changes in plasma cortisol and lymphocyte gluco-corticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995;52:583–93.
   Google Scholar
• Kellner M, Baker DG, Yehuda R. Salivary cortisol in Operation Desert Storm returnees. Biol Psychiatry 1997;42: 849–50.
   Google Scholar
• Yehuda R, Boisoneau D, Mason JW, Giller EL. Glucocorti-coid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol Psychiatry 1993; 34: 18–25.
   PubMed Web of Science ®Google Scholar
• Rinne T, de Kloet R, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/cortico-tropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002;52:1102–12.
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224–34.
   PubMed Web of Science ®Google Scholar
• Parker A J, Wessely S, Cleare A J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001;31:1331–45.
   Google Scholar
• Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendo-crinology 1999;24:759–68.
   PubMed Web of Science ®Google Scholar
• Geenen R, Jacobs JW, Bijlsma JW. Evaluation and manage-ment of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 2002;28:389–404.
   PubMed Web of Science ®Google Scholar
• Licinio J, Wong ML, Gold PW. The hypothalamic-pituitary-adrenal axis in anorexia nervosa. Psychiatry Res 1996;62:75–83.
   Google Scholar
• Invitti C, Redaelli G, Baldi G, Cavagnini F. Glucocorticoid receptors in anorexia nervosa and Cushing's disease. Biol Psychiatry 1999;45:1467–71.
   Google Scholar
• Estour B, Pugeat M, Lang F, Lejeune H, Broutin F, Pellet J, et al. Rapid escape of cortisol from suppression in response to i.v. dexamethasone in anorexia nervosa. Clin Endocrinol (Oxf) 1990;33:45–52.
   Google Scholar
• Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, et al. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol 2001;145:165–71.
   PubMed Web of Science ®Google Scholar
• Neudeck P, Jackoby GE, Florin I. Dexamethasone suppres-sion test using saliva cortisol measurement in bulimia nervosa. Physiol Behav 2001;72:93–8.
   Google Scholar
• Silva SM, Paula-Barbosa MM, Madeira MD. Prolonged alcohol intake leads to reversible depression of corticotropin-releasing hormone and vasopressin immunoreactivity and mRNA levels in the parvocellular neurons of the paraven-tricular nucleus. Brain Res 2002;954:82–93.
   Google Scholar
• Zimmermann U, Hundt W, Spring K, Grabner A, Holsboer F. Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism. Biol Psychiatry 2003;53:75–84.
   Google Scholar
• Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 1991;72:1290–5.
   PubMed Web of Science ®Google Scholar
• von Bardeleben U, Heuser I, Holsboer F. Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuro-endocrinology 1989;14:441–9.
   Google Scholar
• Adinoff B, Martin PR, Bone GH, Eckardt MJ, Roehrich L, George DT, et al. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry 1990;47:325–30.
   PubMedGoogle Scholar
• Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology 1996;21:263–75.
   PubMed Web of Science ®Google Scholar
• Hundt W, Zimmermann U, Pottig M, Spring K, Holsboer F. The combined dexamethasone-suppression/CRH-stimula-tion test in alcoholics during and after acute withdrawal. Alcohol Clin Exp Res 2001;25:687–91.
   Google Scholar
• Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW. The corticotropin-releasing hormone stimula-tion test in patients with panic disorder. Am J Psychiatry 1986;143:896–9.
   Google Scholar
• Suemaru S, Suemaru K, Hashimoto K, Ogasa T, Hirasawa R, Makino S, et al. Cerebrospinal fluid corticotropin-releasing hormone and ACTH, and peripherally circulating choline-containing phospholipid in senile dementia. Life Sci 1993;53:697–706.
   Google Scholar
• Banki CM, Karmacsi L, Bissette G, Nemeroff CB. Cere-brospinal fluid neuropeptides in mood disorder and demen-tia. J Affect Disord 1992;25:39–45.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB. The neurobiological consequences of child-hood abuse. Presentation at the 2003 meeting of the Ameri-can Psychiatric Association, 2003 May 17–22. San Francisco, California, USA.
   Google Scholar
• Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001;49:1023–39.
   PubMed Web of Science ®Google Scholar